| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |